Anaptysbio (ANAB) Equity Ratio (2016 - 2025)
Anaptysbio's Equity Ratio history spans 10 years, with the latest figure at 0.1 for Q4 2025.
- For Q4 2025, Equity Ratio fell 30.28% year-over-year to 0.1; the TTM value through Dec 2025 reached 0.1, down 30.28%, while the annual FY2025 figure was 0.1, 30.28% down from the prior year.
- Equity Ratio reached 0.1 in Q4 2025 per ANAB's latest filing, up from 0.08 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.96 in Q1 2021 to a low of 0.13 in Q2 2025.
- Average Equity Ratio over 5 years is 0.34, with a median of 0.27 recorded in 2023.
- Peak YoY movement for Equity Ratio: rose 2.04% in 2021, then plummeted 677.24% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.55 in 2021, then dropped by 22.53% to 0.43 in 2022, then crashed by 54.65% to 0.19 in 2023, then decreased by 24.79% to 0.15 in 2024, then plummeted by 30.28% to 0.1 in 2025.
- Per Business Quant, the three most recent readings for ANAB's Equity Ratio are 0.1 (Q4 2025), 0.08 (Q3 2025), and 0.13 (Q2 2025).